Literature DB >> 12408074

DFNB3, spectrum of MYO15A recessive mutant alleles and an emerging genotype-phenotype correlation.

Thomas B Friedman1, John T Hinnant, Manju Ghosh, Erich T Boger, S Riazuddin, James R Lupski, Lorraine Potocki, Edward R Wilcox.   

Abstract

We have now identified seven MYO15A mutations that cause congenital profound neurosensory hearing loss and a possible hypomorphic allele of MYO15A associated with moderately-severe hearing loss in 1 of 8 SMS patients. Because myosin XVA is encoded by 66 exons, screening for mutations in hearing-impaired individuals is expensive and labor-intensive in comparison to a screen for mutations in GJB2 (Cx26), for example, which has only a single protein coding exon. Among consanguineous families segregating profound, congenital hearing loss from Pakistan, approximately 10% are consistent with linkage to DFNB3 (11 of 112 DFNB families). In one-half of these DFNB3 families, we found a homozygous mutation in 1 of the 66 exons of MYO15A [25]. This suggests that mutations of MYO15A are responsible for at least 5% of recessively inherited, profound hearing loss in Pakistan. However, without the benefit of a pre-screen for linkage to DFNB3, it will be a challenge to determine the extent to which mutations of MYO15A contribute to hereditary hearing loss among isolated cases and small families in other populations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408074     DOI: 10.1159/000066824

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  8 in total

1.  Age-related changes in cochlear gene expression in normal and shaker 2 mice.

Authors:  Tzy-Wen L Gong; I Jill Karolyi; James Macdonald; Lisa Beyer; Yehoash Raphael; David C Kohrman; Sally A Camper; Margaret I Lomax
Journal:  J Assoc Res Otolaryngol       Date:  2006-06-23

2.  Screening for MYO15A gene mutations in autosomal recessive nonsyndromic, GJB2 negative Iranian deaf population.

Authors:  Zohreh Fattahi; A Eliot Shearer; Mojgan Babanejad; Niloofar Bazazzadegan; Seyed Navid Almadani; Nooshin Nikzat; Khadijeh Jalalvand; Sanaz Arzhangi; Fatemehsadat Esteghamat; Rezvan Abtahi; Batool Azadeh; Richard J H Smith; Kimia Kahrizi; Hossein Najmabadi
Journal:  Am J Med Genet A       Date:  2012-06-26       Impact factor: 2.802

Review 3.  Heterogeneity of Hereditary Hearing Loss in Iran: a Comprehensive Review.

Authors:  Maryam Beheshtian; Mojgan Babanejad; Hela Azaiez; Niloofar Bazazzadegan; Diana Kolbe; Christina Sloan-Heggen; Sanaz Arzhangi; Kevin Booth; Marzieh Mohseni; Kathy Frees; Mohammad Hossein Azizi; Ahmad Daneshi; Mohammad Farhadi; Kimia Kahrizi; Richard Jh Smith; Hossein Najmabadi
Journal:  Arch Iran Med       Date:  2016-10-01       Impact factor: 1.354

4.  Prioritized sequencing of the second exon of MYO15A reveals a new mutation segregating in a Pakistani family with moderate to severe hearing loss.

Authors:  Rasheeda Bashir; Amara Fatima; Sadaf Naz
Journal:  Eur J Med Genet       Date:  2011-12-30       Impact factor: 2.708

Review 5.  Actin in hair cells and hearing loss.

Authors:  Meghan C Drummond; Inna A Belyantseva; Karen H Friderici; Thomas B Friedman
Journal:  Hear Res       Date:  2011-12-13       Impact factor: 3.208

Review 6.  Genetics of hearing and deafness.

Authors:  Simon Angeli; Xi Lin; Xue Zhong Liu
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

7.  Genotype-phenotype correlation analysis of MYO15A variants in autosomal recessive non-syndromic hearing loss.

Authors:  Jing Zhang; Jing Guan; Hongyang Wang; Linwei Yin; Dayong Wang; Lidong Zhao; Huifang Zhou; Qiuju Wang
Journal:  BMC Med Genet       Date:  2019-04-05       Impact factor: 2.103

8.  Identification and Clinical Implications of Novel MYO15A Mutations in a Non-consanguineous Korean Family by Targeted Exome Sequencing.

Authors:  Mun Young Chang; Ah Reum Kim; Nayoung K D Kim; Chung Lee; Kyoung Yeul Lee; Woo-Sung Jeon; Ja-Won Koo; Seung Ha Oh; Woong-Yang Park; Dongsup Kim; Byung Yoon Choi
Journal:  Mol Cells       Date:  2015-08-04       Impact factor: 5.034

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.